IJGC Podcast

In this episode of the IJGC podcast, Editor-in-Chief, Dr. Pedro Ramirez, is joined by Dr. Robert Coleman (Twitter: @rcoledude) from MD Anderson Cancer Center in Houston, Texas, to talk about the role of secondary cytoreductive surgery in recurrent ovarian cancer. They discuss the importance, findings, and implications of surgical clinical trials such as GOG 213 and future studies on recurrent ovarian cancer.

In this episode of the IJGC podcast, Editor-in-Chief, Dr. Pedro Ramirez, is joined by Dr. Michael Frumovitz (Twitter: @Frumovitz) from MD Anderson Cancer Center in Houston, Texas, to talk about the role of sentinel lymph node mapping in cervical cancer. They discuss the uses of ICG and blue dye and other tracers in lymphatic mapping, the details of injection techniques, and how to use these approaches in your practice.

In this episode of the IJGC podcast, Editor-in-Chief, Dr. Pedro Ramirez, is joined by Dr. Juan Luis Alcázar (Twitter: @Juan_L_Alcazar) from the Department of Obstetrics and Gynecology, Clínica Universidad de Navarra in Pamplona, Spain. Dr. Alcázar is the lead author of the Lead Article for the February 2019 issue, "Preoperative assessment of intra-abdominal disease spread in epithelial ovarian cancer: a comparative study between ultrasound and computed tomography scan." They discuss the rationale behind the study, the advantages and limitations of using ultrasound, the recent evolution of ultrasound technology, and recommendations for centers that may be lacking an expert ultrasonographer.

In this episode of the IJGC podcast, Editor-in-Chief, Dr. Pedro Ramirez, is joined by Dr. Robert Soslow from Memorial Sloan Kettering Cancer Center to talk about the importance and clinical relevance of a classification in patients with cervical cancer, particularly cervical adenocarcinoma. They discuss the way that cervical adenocarcinoma has been classified historically, the potential impact of a new classification scheme on clinical outcomes, and integrating testing in low resource areas. Look out for IJGC's upcoming podcast with Dr. Soslow on invasion pattern-based classification of HPV-associated endometrial carcinomas.

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. David Gershenson (Twitter: @RareOvarCancers) from MD Anderson Cancer Center in Houston, Texas to talk about the management of rare ovarian tumors in ovarian cancers, including mucinous, clear cell, and small cell. They discuss metastatic vs. primary mucinous tumors, the role of HIPEC in the treatment of advanced disease, as well as genomic profiling. Look out for IJGC's upcoming pdocast with Dr. Gershenson on updates on management of low-grade ovarian tumors.

In this episode of the IJGC podcast, Editor-in-Chief, Dr. Pedro Ramirez, is joined by Dr. Robert Coleman (Twitter: @rcoledude) from MD Anderson Cancer Center in Houston, Texas. They discuss how parp inhibitors work and how they have come into play with gynecologic oncology, including how to discuss parp inhibitors with patients, recommendations for patient monitoring and follow up, and the future of ovarian cancer treatment.

In this episode of the IJGC podcast, Editor-in-Chief, Dr. Pedro Ramirez, is joined by Dr. Anna Fagotti (Twitter: @annafagottimd) from Policlinico Universitario Agostino Gemelli in Rome. Dr. Fagotti is the lead author of the Lead Article for the February 2018 issue, "The INTERNATIONAL MISSION study: Minimally Invasive Surgery In Ovarian Neoplasms after NACT." They discuss the origins and results of the study, what makes a patient an ideal candidate for minimally invasive surgery, and the next steps for evaluating oncologic outcomes.